Astrazeneca Pharma India Cash Flow Annual

BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020 | Sector: Major Drugs
7,839.35 -108.25 (-1.36%)Updated : 16 May 2025
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 219.54134.1083.04127.09
Depreciation/ Depletion 14.9416.2616.9520.13
Non- Cash Items -22.01-21.06-7.29-5.93
Changesin Working Capital -184.60-71.018.10-36.51
Cashfrom Operating Activities 27.8758.29100.80104.78
Capital Expenditures -10.76-8.52-9.62-7.71
Other Investing Cash Flow Items Total 32.5026.6314.36180.74
Cashfrom Investing Activities 21.7418.114.74173.03
Financing Cash Flow Items -0.52-0.63-0.95-1.09
Total Cash Dividends Paid -40.00-20.00-5.00-5.00
Issuance( Retirement)of Debt Net -3.86-3.85-3.51-2.88
Cashfrom Financing Activities -44.38-24.48-9.46-8.97
Net Changein Cash 5.2351.9296.08268.84
Cash Interest Paid 0.520.630.951.09
Cash Taxes Paid 56.4340.8224.7932.56
period Length 12.0012.0012.0012.00
period Type ----
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,381.00+25.85(1.10%)
2,353.15+22.90(0.98%)
435.60+3.15(0.73%)
1,814.35-52.45 (-2.81%)
1,659.75-36.30 (-2.14%)